Guide · Standards

    IEC 81001-5-1 Security Lifecycle Evidence Table

    Practical IEC 81001-5-1 evidence mapping: lifecycle activities, artifact owners, review questions, and a worked traceability example for health software.

    Hero illustration for the Standards article: IEC 81001-5-1 Security Lifecycle Evidence Table
    On this page
    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA

    Founder & CEO · Blue Goat Cyber

    Published: · Updated:

    Key Takeaways

    • IEC 81001-5-1 covers security lifecycle activities for health software, not just a one-time risk assessment.
    • The IEC catalogue lists the corrected December 2025 version with Interpretation Sheet 1 included.
    • IEC 62304, ISO 14971, and ANSI/AAMI SW96 serve related but distinct purposes.
    • The standard excludes specifying accompanying documentation contents; IFU duties come from applicable law.
    • Evidence needs build-specific traceability and manufacturer approval, not just document titles.
    Direct Answer

    What evidence supports IEC 81001-5-1 security lifecycle activities?

    IEC 81001-5-1:2021 defines lifecycle requirements for the development and maintenance of health software to support conformance to IEC 62443-4-1, with health-software-specific needs taken into account. Organize evidence around secure development, risk management, testing, release, and vulnerability handling. Identify the exact edition and applicable interpretation sheet before performing a conformity assessment.

    Download the matching IEC lifecycle evidence PDF.

    The official IEC catalogue lists the corrected December 2025 version of IEC 81001-5-1:2021, including Interpretation Sheet 1. This is not a new 2025 edition. The standard excludes specification of accompanying documentation contents. Instructions-for-use requirements should be traced to applicable device law rather than attributed to this standard.

    What this table does and does not establish

    The table below is Blue Goat Cyber's practical evidence planning aid. It paraphrases lifecycle work and offers example artifacts, owners, and review questions. It does not reproduce the licensed standard, certify conformity, or assert that each named artifact is a mandatory standalone document. Clause-level assessment requires the licensed text, applicable interpretations, product scope, and your chosen conformity method.

    IEC 81001-5-1 is not an amendment to IEC 62304. A manufacturer can integrate the security activities into an existing software lifecycle and QMS, but the standards have different scopes. Do not infer that conformity with IEC 62304 automatically establishes security lifecycle conformity.

    Lifecycle activity to evidence table

    Lifecycle workExample controlled evidenceManufacturer owner and review question
    Security governance and development planningSecurity development plan, defined product scope, roles, competency records, and lifecycle review criteriaEngineering / QA: Are responsibilities and review criteria established before work begins?
    Security risk managementSecurity risk plan, asset/threat analysis, risk assessment, control decisions, and safety links where relevantProduct security / risk management: Are risks assessed in the intended environment and approved by authorized people?
    Security requirementsDevice-specific requirements with traceability to threats, risks, and applicable external requirementsEngineering / product security: Can each requirement be tested and traced to its reason for existing?
    Secure architecture and designTrust boundaries, data flows, threat model, control allocation, and design rationaleSystem engineering: Are attack surfaces and security assumptions explicit, including connected systems?
    Implementation and component managementSecure coding practices, review records, component inventory or SBOM, and supplier/component assessmentsSoftware engineering: Are implementation and dependency risks controlled for the released configuration?
    Security verification and testingSecurity requirement tests, appropriate vulnerability/abuse-case testing, penetration test evidence, finding disposition, and retest recordsProduct security / engineering: Does evidence demonstrate the controls and account for test limitations?
    Release and configuration controlVersioned evidence index, release configuration, unresolved issue rationale, and authorized release/risk decisionsQA / release authority: Do the assessed build and evidence match what is released?
    Maintenance and security updatesChange impact assessment, updated threat/risk records, patch test evidence, and controlled release recordsMaintenance engineering: Is each change assessed for security and relevant safety effects?
    Vulnerability intake and problem resolutionSecurity contact/intake process, triage records, coordinated disclosure decisions, remediation tracking, and closure evidenceProduct security / PSIRT: Can a reported vulnerability be tracked through assessment, action, and closure?
    Lifecycle monitoring and improvementMonitoring records, recurring issue analysis, process changes, and updated evidenceProduct security / QA: Do new threats and field findings feed back into development and maintenance?

    Some records can be combined. A security development plan may reference controlled QMS procedures rather than copy them. An SBOM can support component management without replacing supplier assessment or vulnerability analysis. A test report does not approve residual risk; that remains a manufacturer decision.

    Confirmed standard areas and interpretation notes

    The official IEC preview confirms the following process headings. Evidence examples remain our planning suggestions, not quotations of the normative requirements.

    IEC areaPractical evidence focus
    4: General requirementsQMS integration, responsibilities, competence, supplier controls, and security issue handling
    4.3: Software-item classification relating to risk transferMAINTAINED, SUPPORTED, and REQUIRED classifications, responsibilities, and support arrangements
    5: Software development processPlans, threats, requirements, architecture, implementation, verification, and release evidence
    6: Software maintenance processMonitoring, impact assessment, security updates, and associated testing and communication
    7: Security risk-management processRisk analysis, controls, verification, and reassessment after changes
    8: Software configuration-management processBaselines, version identification, and controlled change records
    9: Software problem-resolution processInvestigation, vulnerability disposition, correction, and closure evidence
    Annex F: Transitional health softwareApplicable whole-product transitional assessment, not a fourth software-item category or a regulatory exemption

    Interpretation Sheet 1 clarifies software-item categories and risk-transfer activities, vulnerability severity versus risk, monitoring, and update responsibilities. Maintain the classification rationale and reassess it when support arrangements change. The exclusion of accompanying-documentation contents does not mean there are no documentation-related activities: the interpretation sheet also clarifies security-guideline documentation. Use the licensed corrected text for the exact requirements.

    How IEC 62304, SW96, and ISO 14971 relate

    ReferenceMain purposePractical connection
    IEC 62304Medical device software lifecycle processesIntegrate security activities at existing development, maintenance, configuration, and problem-resolution checkpoints; assess each standard separately
    IEC 81001-5-1Security lifecycle activities for health softwareOrganize secure development and maintenance activities with controlled evidence
    ANSI/AAMI SW96:2023Medical device security risk managementApply a security risk management method alongside lifecycle activities; it is not replaced by a lifecycle evidence table
    ISO 14971:2019Medical device risk managementLink security findings to hazardous situations and harm where relevant; security-specific methods and scales may remain distinct

    No one-to-one equivalence should be assumed between all clauses of these standards. Check the exact editions and any applicable regulatory recognition or harmonization. Recognition of a standard is not the same as a blanket legal mandate to use it.

    Worked traceability example: a software update path

    This fictional example is not a client case or evidence of a regulator's acceptance. A connected device receives software updates through a maintenance service.

    LinkExample recordWhat to check
    ThreatTM-14: an unauthorized actor supplies a modified updateArchitecture identifies the update source, trust boundary, credentials, and delivery path
    Security requirementSEC-22: the device authenticates and checks update integrity before installationRequirement describes rejection behavior and the supported configuration
    ImplementationDES-22: verification control and protected trust materialDesign accounts for key management, failure handling, and deployment assumptions
    Security evidenceTEST-22: altered and unauthorized packages are rejected in the assessed buildTest environment, inputs, results, limitations, and build identifiers are retained
    Finding dispositionFIND-08: an alternative service path bypasses the controlManufacturer remediates or documents a justified risk decision; linked retest evidence records the outcome
    Release and maintenanceREL-07 and CHG-09 reference the approved evidence setReleased versions and later update-path changes are covered by the correct assessment

    Whether exploitation could create a hazardous situation depends on the device and clinical use. Link to the safety risk analysis when relevant; do not infer patient risk or acceptability from a vulnerability score alone.

    How the evidence supports regional files

    For the EU MDR/IVDR evidence crosswalk, reference lifecycle records against the applicable GSPRs and technical-documentation sections. For Japan, assess the applicable Japanese requirements and JIS mapping. For the UK, distinguish Great Britain from Northern Ireland before choosing legal anchors.

    For the US, the FDA February 3, 2026 premarket cybersecurity guidance explains expected cybersecurity content. A lifecycle table can organize supporting evidence, but does not substitute for guidance-specific content or applicable Section 524B obligations. Do not claim that using this table alone produces an acceptable submission.

    Practical gap review

    1. Define health-software scope, product versions, and applicable standards/interpretations.
    2. Map lifecycle activities to existing QMS processes without duplicating procedures.
    3. Index actual artifacts with revisions, build IDs, owners, and approval status.
    4. Follow a sample threat through requirements, design, test, disposition, and release.
    5. Confirm component changes and new vulnerability reports trigger reassessment.
    6. Record evidence gaps and assign corrective work, rather than marking a document title as complete.
    7. Obtain manufacturer approval for risk and release decisions.

    Typical gaps include a threat model that predates the released architecture, component data with no vulnerability follow-up, tests that cannot be tied to the released build, and risk decisions with no authorized approver.

    How Blue Goat Cyber helps

    We support cybersecurity gap reviews, threat modeling, security risk assessment, SBOM evidence, penetration testing, and scoped cybersecurity QMS integration. General software verification and validation, QMS ownership, certification, and regulatory approval remain outside that cybersecurity service scope. The manufacturer retains risk and release authority. See premarket cybersecurity support or book a discovery call.

    FAQ

    Is IEC 81001-5-1 just a risk assessment standard?

    No. It addresses security activities across health-software development and maintenance. Risk management is part of that lifecycle, not the complete scope.

    Is this a clause-by-clause conformity checklist?

    No. It is a practical activity-to-evidence table. Use the licensed standard and applicable interpretation sheet for a formal clause-level assessment.

    Does IEC 81001-5-1 specify IFU contents?

    No. The IEC catalogue explicitly states that specification of accompanying documentation contents is excluded. Trace IFU duties to applicable regulation and use guidance to explain implementation.

    Does it replace SW96 or ISO 14971?

    No. Those references serve related but distinct risk management purposes. Integrate evidence and safety links where relevant without assuming identical scope or rating scales.

    Is the corrected December 2025 version a new edition?

    No. The IEC catalogue still identifies IEC 81001-5-1:2021, edition 1.0, with the corrected version incorporating Interpretation Sheet 1 from December 2025.

    Sources and primary references

    Sources & references

    Primary sources cited in this article. Links open in a new tab.

    1. official IEC catalogue- IEC
    2. Interpretation Sheet 1- IEC
    3. FDA February 3, 2026 premarket cybersecurity guidance- U.S. FDA
    4. IEC 62304:2006 with Amendment 1:2015- ISO
    5. ISO 14971:2019- ISO
    6. European Commission: harmonized standards for medical devices- health.ec.europa.eu
    Related. FDA Cybersecurity Guidance

    Continue exploring this topic

    Ready when you are

    Secure your device before it reaches patients.

    30-minute strategy session. No cost, no commitment - just answers from people who've supported 275+ FDA submissions, with zero cybersecurity rejections.